Penumbra PEN shares ended the last trading session 3.3% higher at $203.22. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock’s 11.8% gain over the past four weeks.
Penumbra scored a strong price increase on investors’ optimism surrounding its impending second-quarter 2024 financial results, which is slated to release on Jul 30 post the closing bell. The Zacks Consensus Estimate for the second quarter revenue and earnings indicate 14.2% and 30.2% respective growths, year over year. The company had a strong start to the year, with U.S. thrombectomy revenue growing 35.2% in the first quarter.
This medical device maker is expected to post quarterly earnings of $0.56 per share in its upcoming report, which represents a year-over-year change of +30.2%. Revenues are expected to be $298.5 million, up 14.2% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Penumbra, the consensus EPS estimate for the quarter has been revised marginally lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn’t usually translate into price appreciation. So, make sure to keep an eye on PEN going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here >>>>
Penumbra is part of the Zacks Medical – Instruments industry. Inogen INGN, another stock in the same industry, closed the last trading session 1.3% lower at $9.62. INGN has returned 27.5% in the past month.
For Inogen
Buy 5 Stocks BEFORE Election Day
Biden or Trump? Zacks is releasing a FREE Special Report, Profit from the 2024 Presidential Election (no matter who wins).
Since 1950, presidential election years have been strong for the market. This report names 5 timely stocks to ride the wave of electoral excitement.
They include a medical manufacturer that gained +11,000% in the last 15 years… a rental company absolutely crushing its sector… an energy powerhouse planning to grow its already large dividend by 25%… an aerospace and defense standout that just landed a potentially $80 billion contract… and a giant chipmaker building huge plants in the U.S.
Penumbra, Inc. (PEN) : Free Stock Analysis Report
Inogen, Inc (INGN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
